GCTK (GlucoTrack, Inc. Common Stock) Stock Analysis - Financials

GlucoTrack, Inc. Common Stock (GCTK) is a publicly traded Healthcare sector company. As of May 21, 2026, GCTK trades at $0.47 with a market cap of $1.77M and a P/E ratio of 0.01. GCTK moved -13.39% today. Year to date, GCTK is -87.99%; over the trailing twelve months it is -94.71%. Its 52-week range spans $0.44 to $2,970.00. Rallies surfaces GCTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are GCTK's key financials?

GCTK financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GCTK recently traded at $0.47. Market cap is $1.77M. P/E ratio is 0.01. Revenue is $0.

GCTK Key Metrics

Key financial metrics for GCTK
MetricValue
Price$0.47
Market Cap$1.77M
P/E Ratio0.01
EPS$31.22
Dividend Yield0.00%
52-Week High$2,970.00
52-Week Low$0.44
Volume39.26K
Avg Volume0
Revenue (TTM)$0
Net Income$-19.39M
Gross Margin0.00%

GCTK Annual Financials

YearRevenueNet IncomeEPS
2025$0$-19.39M$31.22
2024$0$-22.60M$68.44
2023$0$-7.10M$0.38
2022$0$-4.43M$0.29

Latest GCTK News

Recent GCTK Insider Trades

  • SYCOFF DREW bought 182.54K (~$230.00K) on Apr 22, 2024.

GCTK Analyst Consensus

GCTK analyst coverage data. Average price target: $0.00.

Common questions about GCTK

What are GCTK's key financials?
GCTK financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. GCTK recently traded at $0.47. Market cap is $1.77M. P/E ratio is 0.01. Revenue is $0.
Is GCTK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GCTK. It does not provide personalized investment advice.
GCTK

GCTK